4ZG.F 2.82 (-4.08%)
FR0011049824Medical Diagnostics & ResearchDiagnostics & Research

Median Technologies (4ZG.F) Competitor Comparison

We are evaluating the key criteria listed to compare Median Technologies (4ZG.F) against its competitors in the Diagnostics & Research industry.

Performance 10 years - 4ZG.F ranking 0 / 58

These are the competitors of Median Technologies in the industry Diagnostics & Research ranked by performance 10 years
1. Heska HSKA
1.65K
2. Lantheus Holdings LNTH
1.5K
3. Medpace Holdings MEDP
1.05K
4. Natera NTRA
739.72
5. RadNet RDNT
544.63
6. IDEXX Laboratories IDXX
451.9
7. DexCom DXCM
378.29
8. Thermo Fisher Scientific TMO
279.67
9. Mettler-Toledo MTD
260.75
10. Danaher DHR
259.82
11. PerkinElmer PKI
247.07
12. CareDx CDNA
238.95
13. Twist Bioscience TWST
229.92
14. Waters WAT
193.5
15. Agilent Technologies A
186.68
16. IQVIA Holdings IQV
176.25
17. Icon ICLR
159.03
18. Quest Diagnostics DGX
118.3
19. Laboratory Corp of America Holdings LH
114.64
20. Syneos Health SYNH
113.83
21. Charles River Laboratories CRL
99.62
22. NeoGenomics NEO
98.39
23. Exact Sciences EXAS
89.53
24. Fulgent Genetics FLGT
85.56
25. Guardant Health GH
66.13
26. Meridian Bioscience VIVO
60.69
27. Qiagen QGEN
49.21
28. Inotiv NOTV
36.14
29. Anixa Biosciences ANIX
14.91
30. Ortho Clinical Diagnostics Holdings OCDX
13.74
31. National Research NRC
-5.68
32. Olink Holding OLK
-26.82
33. Bioventus BVS
-36.09
34. Neogen NEOG
-52.85
35. Illumina ILMN
-53.26
36. Sotera Health SHC
-55.93
37. Global Cord Blood CO
-66.57
38. Myriad Genetics MYGN
-72.84
39. Sera Prognostics SERA
-74.75
40. DarioHealth DRIO
-75.47
41. Pacific Biosciences of California PACB
-76.83
42. Exagen XGN
-76.9
43. Enzo Biochem ENZ
-77.8
44. MaxCyte MXCT
-81.81
45. Co-Diagnostics CODX
-83.5
46. Personalis PSNL
-84.92
47. Psychemedics PMD
-85.17
48. MDxHealth MDXH
-86.83
49. bioAffinity Technologies BIAF
-88.45
50. Biodesix BDSX
-92.64
51. SeqLL SQL
-95.22
52. Prenetics Global PRE
-96.61
53. Neuronetics STIM
-97
54. Aspira Womens Health AWH
-97.44
55. Trinity Biotech TRIB
-98.9
56. Organovo Holdings ONVO
-99.26
57. Interpace Biosciences IDXG
-99.49
58. Precipio PRPO
-99.74

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.